# Melatonin for Delirium Prophylaxis

> **NCT02282241** · PHASE4 · WITHDRAWN · sponsor: **University of British Columbia**

## Conditions studied

- Delirium

## Interventions

- **DRUG:** Melatonin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02282241
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-02
- **Primary completion:** 2021-09
- **Final completion:** 2021-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Project never began
- **Last updated:** 2021-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02282241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02282241, "Melatonin for Delirium Prophylaxis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02282241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*